Morepen Laboratories Limited has submitted a regulatory disclosure pursuant to Regulation 30 of SEBI Listing Regulations regarding the favorable outcome of a legal matter concerning GST refund claims.
The disclosure references previous intimations dated 4th December 2025 and 8th January 2026 regarding a Show Cause Notice (SCN) issued by the Office of the Commissioner, Central GST & Central Excise Commissionerate, Shimla. The SCN sought recovery of ₹117,94,03,452 (₹117.94 crore) towards excess GST refund, along with applicable interest and penalty. This notice had been stayed by the Hon'ble High Court of Himachal Pradesh at Shimla.
The Hon'ble High Court, vide its judgment and order dated 12th October 2026, quashed the aforesaid SCN and disposed of the writ petition in favor of the Company. The Company received this order on 14th October 2026 at 3:00 p.m.
Details of the Legal Action
- Authority: Hon'ble High Court of Himachal Pradesh at Shimla
- Nature of Action: The Court quashed the SCN issued by the Office of the Commissioner, Central GST & Central Excise Commissionerate, Shimla, on 2nd December 2025. The SCN had sought recovery of ₹117,94,03,452 towards excess GST refund along with applicable interest and penalty.
- Date of Order: 12th October 2026 (received by Company on 14th October 2026 at 3:00 p.m.)
- Alleged Violation: The SCN alleged that the Company had contravened Section 54 of the CGST Act, 2017, read with Rule 89 of the CGST Rules, 2017, by erroneously claiming an excess GST refund under Rule 89(4) of the CGST Rules, 2017.
Financial Impact
As explicitly stated in the disclosure: "There is no impact on financials, operations or other activities of the company."